SuperworthCitroTech price to sales ratio CITR
Market value divided by revenue over the last twelve months, since 2025.
- Today, Oct 23, 2026
- 44.3×
- Peer median
- 0.8×
CitroTech's price to sales ratio is 44.3× as of Oct 23, 2026.
It has traded since Nov 28, 2025, and over that time its price to sales ratio ranged from 44.3× in Oct 2026 to 117× in Aug 2026.
The median for 3 chemicals stocks of a similar size is 0.8×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 44.3× | 44.3× | 117× |
| 2025 | 74.1× | 62.0× | 74.1× |
Against its peers
Companies in Chemicals nearest CitroTech's size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| CITRCitroTech | 44.3× |
| FTLFFitlife Brands | 0.8× |
| BTMDbiote | 0.2× |
| NAGENiagen Bioscience | 1.5× |
| Peer median | 0.8× |
Where CitroTech ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on CitroTech
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.